APA (7th ed.) Citation

Tina Krieger, Isobel Pearson, Judith Bell, Jim Doherty, & Paul Robbins. (2020). Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment. BMC.

Chicago Style (17th ed.) Citation

Tina Krieger, Isobel Pearson, Judith Bell, Jim Doherty, and Paul Robbins. Targeted Literature Review on Use of Tumor Mutational Burden Status and Programmed Cell Death Ligand 1 Expression to Predict Outcomes of Checkpoint Inhibitor Treatment. BMC, 2020.

MLA (9th ed.) Citation

Tina Krieger, et al. Targeted Literature Review on Use of Tumor Mutational Burden Status and Programmed Cell Death Ligand 1 Expression to Predict Outcomes of Checkpoint Inhibitor Treatment. BMC, 2020.